Clinical Trial Update: The Synapse Project [Phase 2]

View source ↗

Summary

The Phase 2 Synapse Project evaluating Alzheimer's disease has completed. Results were posted on 2025-08-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-08-12